SARS News and Research

RSS

Researchers show how investigational antiviral drug stops coronavirus

A team of academic and industry researchers is reporting new findings about how exactly an investigational antiviral drug stops coronaviruses.

28 Feb 2020

New studies explore risk factors and public health concerns over coronavirus

Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response. JACEP Open, a new official open access journal of the American College of Emergency Physicians (ACEP), explores coronavirus (COVID-19) concerns in two new analyses.

28 Feb 2020

New compounds may help stop the spread of the coronavirus

Amid the global health crisis of the coronavirus (COVID-19), scientists from around the world are racing to find a treatment to stop the deadly virus. The sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across 46 countries, infecting more than 82,000 and killing more than 2,800 people.

26 Feb 2020

Mount Sinai physicians first in the U.S. to analyze chest CT scans of patients with COVID-19

Mount Sinai Health System physicians--the first experts in the country to analyze chest computed tomography (CT) scans of patients from China with coronavirus disease (COVID-19)--have identified specific patterns in the lungs as markers of the disease as it develops over the course of a week and a half.

26 Feb 2020

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, today announced the launch of a Pilot investigator-initiated clinical trial with APN01, a recombinant human angiotensin-converting enzyme 2, to treat patients with severe coronavirus infection in the People's Republic of China.

26 Feb 2020

Coronavirus vaccine trials commence

The coronavirus disease (COVID-19) outbreak has swept the world, killing 2,770 people and infecting more than 81,000. Amid the health crisis, scientists from across the globe are racing to develop novel therapies and vaccines in the hope of stemming the spread of the deadly virus.

26 Feb 2020

HKUST scientists provide leads for guiding research towards COVID-19 vaccine development

A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of potential vaccine targets for the SARS-CoV-2 coronavirus, providing crucial leads for guiding experimental efforts towards the vaccine development against the novel pneumonia (COVID-19) caused by the virus.

26 Feb 2020

Promega's custom manufacturing capabilities support rapid development of Logix Smart COVID-19 Test

Promega Corporation is being recognized by Utah-based Co-Diagnostics, Inc.

From Promega Corporation 26 Feb 2020

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center in Omaha.

25 Feb 2020

Scientists join forces to combat coronavirus outbreak

Amid the coronavirus disease (COVID-19) outbreak, scientists from around the globe race to fight the deadly virus. Now, a team of Harvard scientists has joined forces with Chinese experts to develop new therapies and prevent the further spread of the virus.

25 Feb 2020

Harvard scientists will join forces with Chinese colleagues on coronavirus research

Since its identification in December, the novel coronavirus has quickly evolved into a global threat, taking a toll on human health, overwhelming vulnerable health care systems and destabilizing economies worldwide.

24 Feb 2020

Coronavirus incubation period could be 27 days, longer than previously thought

Over the past weeks, health officials around the globe traced and advised suspected contacts of people with the coronavirus disease (COVID-19) to isolate themselves for 14 days, the incubation period of the disease.

24 Feb 2020

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Back in February 2018, the World Health Organization (WHO) talked about a new virus that will emerge and wreak havoc across the globe. Disease X was the term used for this new unknown pathogen that might cause a future epidemic.

23 Feb 2020

Consumers more likely to purchase cold and flu products over coronavirus fears, says GlobalData

The start of 2020 has been defined by Coronavirus, which to date has killed over 1,000 people and impacted the lives of thousands more.

21 Feb 2020

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

From working to develop one of the first nonhuman primate models for the 2019 novel coronavirus disease (COVID-19) to designing new therapeutic strategies and nanotechnology-based tests to rapidly diagnose infections, researchers at Tulane University are responding across disciplines to the emerging coronavirus epidemic.

21 Feb 2020

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

Four research teams at Columbia University will share a $2.1 million grant to mount an aggressive effort to identify potential antiviral drugs and antibodies for use against the new coronavirus, 2019-nCoV.

20 Feb 2020

Vaccine for COVID-19 coronavirus could soon be a reality

A team of researchers from the University of Texas at Austin and the National Institutes of Health have managed to make significant progress in the development of a vaccine against the fast-spreading and virulent COVID-19/Novel coronavirus that started in Wuhan, Hubei province of China in December 2019 and is still infecting thousands.

19 Feb 2020

Coronavirus is deadlier than flu with seniors at highest risk

The novel coronavirus (CoV) is a new strain of coronavirus that has not been previously identified in humans. The new, or “novel” coronavirus, now called 2019-nCoV, had not previously detected before the outbreak was reported in Wuhan, China in December 2019.

19 Feb 2020

Study identifies new CoV responsible for the Wuhan outbreak

The 2019 novel coronavirus causes fatal pneumonia that has claimed over 1300 lives, with more than 52000 confirmed cases of infection by February 13, 2020, all in the span of just over a month.

18 Feb 2020

UT Southwestern scientists discover potential vulnerabilities in new coronavirus

UT Southwestern Medical Center data scientists analyzing genetic sequences of the COVID-19 coronavirus have identified potential vulnerabilities that could help in vaccine development and further study of the infectious disease now spreading worldwide.

17 Feb 2020

SARS News and Research

Researchers show how investigational antiviral drug stops coronavirus

New studies explore risk factors and public health concerns over coronavirus

New compounds may help stop the spread of the coronavirus

Mount Sinai physicians first in the U.S. to analyze chest CT scans of patients with COVID-19

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

Coronavirus vaccine trials commence

HKUST scientists provide leads for guiding research towards COVID-19 vaccine development

Promega's custom manufacturing capabilities support rapid development of Logix Smart COVID-19 Test

Clinical trial to evaluate safety, efficacy of remdesivir in adults with COVID-19 begins

Scientists join forces to combat coronavirus outbreak

Harvard scientists will join forces with Chinese colleagues on coronavirus research

Coronavirus incubation period could be 27 days, longer than previously thought

Is COVID-19 the dreaded ‘Disease X' scientists warned us about?

Consumers more likely to purchase cold and flu products over coronavirus fears, says GlobalData

Tulane establishes COVID-19 research program to develop a vaccine and test treatments

Columbia teams receive $2.1 million grant to find potential antiviral drugs for 2019-nCoV

Vaccine for COVID-19 coronavirus could soon be a reality

Coronavirus is deadlier than flu with seniors at highest risk

Study identifies new CoV responsible for the Wuhan outbreak

UT Southwestern scientists discover potential vulnerabilities in new coronavirus

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News